What you already have
A syndicated subscription. Useful for the market total. Weak when you need brand vs competitor at a named account in a named country.
BioNixus is a global primary market research firm that delivers account-level and SKU-level brand versus competitor data in 48 countries. Syndicated data feeds miss subaccounts, traditional trade, and country-level breakdowns. Field teams run the study; a proposal is ready within 48 hours of your brief.
Account
vs national average
The breakdown IQVIA and Nielsen skip
Coverage
48
countries
Fieldwork
120+
studies a year
Proposal
48h
from your brief
Trusted by 118 global clients · 120+ projects annually · 127 in 2025 · 48 countries
The gap
Marketing and commercial teams already pay for a syndicated feed. It tells them the national share. It does not tell them which hospital, department, retailer, distributor, or SKU is moving it — or what is happening in traditional trade. Those are the breakdowns that change a launch or a share plan.
A syndicated subscription. Useful for the market total. Weak when you need brand vs competitor at a named account in a named country.
Subaccounts. Subregions. Traditional trade. SKU-level performance. The local affiliate cannot brief a campaign from a global average.
Primary research designed for that breakdown. Local teams run the study. You get a decision pack — not a recycled dashboard export.
Methodology
Three steps. One commercial question. A proposal in 48 hours — then fieldwork in the country you named.
Tell us the brand, the country, the competitor set, and the breakdown you cannot get from syndicated subscriptions. We scope the study around that question — not a template deck.
Local teams run interviews, surveys, mystery shops, or account visits. Multilingual where the market needs it. Identity and quality checks on every wave.
Charts and findings a Head of Marketing can take to the commercial director. Comparable across countries when you need a regional roll-up.
Services
Primary studies scoped to a brand, a country, and a decision — not a recycled global feed. Healthcare is where we are deepest. The same fieldwork runs for FMCG, retail, and B2B.
Quantify how your brand stacks up against named competitors in a specific country — share, perception, and the accounts that move the number.
Hear why customers choose you or the competitor — interviews, groups, and shopper work your dashboard cannot invent.
Pressure-test pricing, access, and the story marketing will take to market — before you spend the launch budget.
Name the accounts, buyers, and influencers who actually decide — hospitals, retailers, distributors, or committees — so the local affiliate knows where to go first.
Field the same design across the United States, UK, Germany, France, Italy, Spain, Saudi Arabia, the UAE, Egypt, Kuwait, Qatar, and APAC priority markets — comparable enough to roll up, local enough to act.
Senior-led design, respondent checks, and charts a marketing head can put in a leadership pack. GDPR-aware fieldwork. Audit-ready when the category requires it.
Have a country, a brand, and a breakdown your dashboard cannot give?
Request a proposal48 countries · local field teams
Keep the syndicated subscriptions — add the breakdown they miss
Healthcare, FMCG, retail, and B2B
48-hour proposal · country pricing
Industries
Healthcare is where we are deepest. FMCG, retail, and B2B get the same account-level design — not a side door on a pharma site.
Launch, access, and brand vs competitor work in hospitals and pharmacies.
Explore Pharma & HealthcareEnterprise and institutional buyers — accounts, not only categories.
Explore B2B IndustriesShopper, brand, and traditional-trade breakdowns your panel average misses.
Explore FMCG & retail120+
Global projects annually
16
Industry verticals
48
global markets in Europe, Americas, APAC and MEA
A short overview of how BioNixus turns a brand-versus-competitor question into a scoped study — with a healthcare example from markets in the Americas, Europe, and the Middle East.


Country and category notes your marketing team can use — not a generic newsletter

UAE healthcare trends 2026: dual-emirate DHA/DOH access, payer tightening, specialty and biosimilar mix, and how to design research that is not a GCC average.

NMPA Class III medical device registration timeline 2026: CMDE review, clinical evaluation options, Resident Agent duties, and 18–36 month planning bands for China launch sequencing.

China medical device VBP rounds explained for 2026: stent and joint price-cut examples, win vs lose outcomes, renewals, localization scoring, and private-hospital escape valves.
Client reviews
Read verified Google reviews from our London office and notes from manufacturers and local affiliates across healthcare, consumer, and enterprise work.
Industry Leaders We Serve Alongside
How marketing and commercial teams used primary fieldwork to decide a launch or a country plan

Read how BioNixus shaped a Top-10 pharma’s GCC oncology launch strategy with quantitative physician surveys and competitive intelligence.

See how BioNixus helped a mid-cap biotech accelerate EMEA expansion with multi-country KOL mapping and market access diagnostics.

Discover how BioNixus delivered launch-readiness evidence for a specialty pharma entering three European markets with payer and hospital research.
Start with the country or the competitor you already have on the brief. Healthcare paths are below because that is where most inbound arrives. Compare methods in our healthcare market research hub, or go to the market researchlibrary.
Country programs for pharmaceutical and healthcare marketing teams — launch, access, and brand vs competitor evidence.
Country-Level DepthFDA-aligned pharmaceutical and healthcare market research intelligence for launch, access, and growth in KSA.
Best for country-level execution
UAE PriorityDubai and Abu Dhabi healthcare intelligence for drug development, market access, and quantitative and qualitative research across the Emirates.
Best for UAE launch and access execution
GCC PriorityGCC-focused pharmaceutical evidence programs for launch sequencing, market access, and cross-country execution.
Best for Middle East launch and access decisions
Full capability overview: 120+ global projects annually (127 in 2025), 118 global clients, dual-practice healthcare and consumer research across Egypt and MENA.
See our market research portfolio
New GuideIndependent guide comparing 5 leading firms for healthcare, pharma, and consumer research in Egypt — the largest market in MENA.
Best for Egypt partner selection
Featured GuideExecution-ready 2026 guide for survey architecture, tracker governance, and AI-assisted validation in Saudi Arabia and UAE.
Best for quantitative design decisions
Cross-IndustryExplore pharma and healthcare, B2B, and B2C market research — the same rigor behind 120+ global projects annually (127 in 2025) across 16 industry verticals.
Explore the industries hub
Country-Level DepthDiscover market research pages by country and region to support pharmaceutical and enterprise strategy worldwide.
Best for multi-country planning
Indexed destinations
Each URL is a decision page — country programs, competitor alternatives, and reports a marketing team can brief from.
Keep the subscription. Those feeds give you the country total. They typically miss subaccounts, traditional trade, and account-level or SKU-level brand versus competitor breakdowns. BioNixus fields the primary study for that gap. You do not switch vendors — you add the breakdown the dashboard cannot give.
Account-level data is brand versus competitor evidence broken down by a named customer account — a hospital, retailer, or distributor — not only a national average. SKU-level data adds the same breakdown by product for a named brand in a named country. Typical 2026 pricing bands and a machine-readable /pricing.md file are on the pricing page.
No. Healthcare is where we are deepest. The same sampling and senior-led analysis run for FMCG, retail, manufacturing, and other B2B and B2C categories. Use the industries hub for those doors. Use the healthcare hub when the brief is launch or access.
BioNixus fields primary research in 48 countries across the Americas, Europe and the United Kingdom, Asia-Pacific, and the Middle East and North Africa — including the United States, the UK, Germany, France, Italy, Spain, Saudi Arabia, the UAE, Egypt, Kuwait, and Qatar. Studies can be one country or several, with a comparable design when you need a regional roll-up.
Manufacturers and their local affiliates. The champion is usually a Head of Marketing working with a Commercial Director. Typical briefs: how we stack up vs competitors in this country, at this account, on this SKU. Too-small firms and teams that only need a syndicated dashboard are not a fit.
After a short scope on the decision, the audience, the markets, and the method, BioNixus typically sends a proposal within 48 hours. Pricing is by project and by country. Typical 2026 bands are on the pricing page. Field timelines depend on incidence, survey length, and seasonality — those dates are in the proposal.
Yes. Multi-country programs use a consistent instrument where the decision needs comparability, plus local recruitment and language. The aim is a roll-up the regional marketing team can use without pretending every market is the same.
Projects use privacy-by-design handling for GDPR and local rules where they apply. Healthcare studies add the ethics and identity checks that category needs. Quality controls and documentation are scoped up front so audit and legal teams are not surprised later.
Read what account-level data is, check pricing bands, or send the brief. Case studies and the methodology section on this page show how a study runs. For a tailored scope, request a proposal or email admin@bionixus.com.
Name the brand, the country, and the breakdown your syndicated feed cannot give you. We send a project- and country-priced proposal — typically within 48 hours.
US No. +1 888 465 5557Europe No. +44 7727 666682Middle East, Africa and Asia No. +20 120 688 2323
Name the brand, the country, and the breakdown your dashboard misses. The contact page has the full form. We typically send a scoped proposal within 48 hours.
Prefer email? admin@bionixus.com
Open the full contact form